☆ 4.7 Editorial Material

Immune response to SARSCoV-2 infection and vaccination in patients receiving kidney replacement therapy

KIDNEY INTERNATIONAL (2021)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Aurelien Sokal et al.

Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.

CELL (2021)

Add to Collection

Letter Urology & Nephrology

Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit

Jorge J. Canas et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Editorial Material Urology & Nephrology

The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action

Anna Francis et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Biology

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus

Mikail Dogan et al.

Summary: Development of highly sensitive SARS-CoV-2-specific antibody and neutralization assays revealed that hospitalized individuals have higher IgG antibody responses and neutralization titers compared to outpatient or convalescent plasma donors, providing insights into the host humoral response to SARS CoV-2.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Letter Urology & Nephrology

Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program

Sarah Gleeson et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Medicine, General & Internal

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Paul A. Kristiansen et al.

LANCET (2021)

Add to Collection

Letter Urology & Nephrology

SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population

Moritz Anft et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Urology & Nephrology

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients

Philippe Attias et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms

Roseanne E. Billany et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients

Noa Berar Yanay et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine

Ilies Benotmane et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Urology & Nephrology

Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

Candice L. Clarke et al.

Summary: Patients with end stage kidney disease receiving in-center hemodialysis have durable immune responses six months post SARS-CoV-2 infection, with fewer than 3% of patients showing no evidence of humoral or cellular immunity.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won

Massimo Torreggiani et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Letter Urology & Nephrology

Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

Ilies Benotmane et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Cell Biology

Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection

Arunasingam Abayasingam et al.

Summary: The study suggests that while neutralizing antibodies in plasma may decline, the neutralizing capacity can still be maintained in the memory B cell repertoire. These memory B cells are capable of continuously producing antibodies with neutralizing capacity against SARS-CoV-2.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nina Le Bert et al.

NATURE (2020)

Add to Collection

Article Urology & Nephrology

Outcomes of patients with end -stage kidney disease hospitalized with COVID-19

Jia H. Ng et al.

KIDNEY INTERNATIONAL (2020)

Add to Collection

Letter Urology & Nephrology

Significant impact of COVID-19 on organ donation and transplantation in a low-prevalence country: Australia

Steven J. Chadban et al.

KIDNEY INTERNATIONAL (2020)

Add to Collection

Article Medicine, General & Internal

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

E. J. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.